Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have released updated consensus guidelines and an associated reproducibility study to standardize how pathologists assess tumor response to neoadjuvant therapy (administered prior to surgery) across a dozen solid tumor types.
Source: https://medicalxpress.com/news/2026-02- ... rgery.html
-
Translation